OMEGAPHARM CEFTAZIDIME FOR INJECTION ceftazidime (as pentahydrate) 2g powder for injection vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

ceftazidime pentahydrate, Quantity: 2349 mg (Equivalent: ceftazidime, Qty 2000 mg)

可用日期:

Omegapharm

INN（国际名称）:

ceftazidime pentahydrate

药物剂型:

Injection, powder for

组成:

Excipient Ingredients: sodium carbonate

给药途径:

Intravenous

每包单位数:

5 vials, 1 vial

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

OMEGAPHARM CEFTAZIDIME FOR INJECTION is indicated for the treatment of single and mixed infections caused by susceptible aerobic organisms with suspected or documented resistance to other antimicrobials, but not to ceftazidime; as an alternative to aminoglycosides in pseudomonal infection in patients in whom aminoglycoside toxicity is a cause for concern and other antipseudomonal antibiotics cannot be used. . Indications include the following.. Severe infections in general. For example: septicaemia (including neonatal sepsis), bacteraemia; in patients in intensive care units with specific problems, e.g. infected burns.. Respiratory tract. For example: pneumonia, bronchopneumonia, infected pleurisy, infected bronchiectasis and bronchitis.. Severe ear, nose and throat infections. For example: otitis media, mastoiditis.. Urinary tract. For example: acute and chronic pyelonephritis, pyelitis, cystitis, urethritis (bacterial only); infections associated with bladder and renal stones.. Skin and soft tissue. . For e

產品總結:

Visual Identification: White or cream coloured powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

授权状态:

Registered

授权日期:

2010-10-19